Gabriela M Witek

Polo-like kinase 1 as a therapeutic target for malignant peripheral nerve sheath tumors (MPNST) and schwannomas.

N. Ratner, J. Field, D. C. Schultz, 2020, American journal of cancer research.

Comprehensive pharmacological profiling of neurofibromatosis cell lines.

J. Field, D. C. Schultz, S. Berritt, 2017, American journal of cancer research.

Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma

J. Maris, Y. Mossé, M. Lemmon, 2023, Nature communications.